LKT Labs

Biochemicals for Life Science Research

[Des-Pro2]-Bradykinin

[Des-Pro2]-Bradykinin

Product ID B6808
Cas No. 80943-05-1
Purity ≥95%
Product Unit SizeCostQuantityStock
5 mg $75.70 Please Inquire
10 mg $129.30 Please Inquire
25 mg $226.90 Please Inquire
Bulk Quote

Quicklinks

Description

Bradykinin is a peptide that exhibits natriuretic, antioxidative, vasodilatory, and pro-angiogenic activities. Bradykinin stimulates bradykinin receptors and increases PLC activity, decreasing ENaC open probability, inhibiting distal nephron Na+ transport, and inducing natriuresis. In vitro, bradykinin decreases H2O2-induced senescence, increases activity of superoxide dismutase (SOD), and suppresses DNA damage, ROS production, and NADPH oxidase activity. Additionally, bradykinin increases expression of VEGF and promotes tube formation in prostate cancer cells.

Product Info

Cas No.

80943-05-1
Purity

≥95%
Formula

C45H66N14O10
Formula Wt.

963.12
Solubility

Soluble in water.

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

B6808 MSDS PDF
Info Sheet

B6808 Info Sheet PDF

References

Mamenko M, Zaika O, Pochynyuk O. Direct regulation of ENaC by bradykinin in the distal nephron. Implications for renal sodium handling. Curr Opin Nephrol Hypertens. 2014 Mar;23(2):122-9. PMID: 24378775.

Yu HS, Wang SW, Chang AC, et al. Bradykinin promotes vascular endothelial growth factor expression and increases angiogenesis in human prostate cancer cells. Biochem Pharmacol. 2014 Jan 15;87(2):243-53. PMID: 24225154.

Dong R, Xu X, Li G, et al. Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state. PLoS One. 2013 Oct 25;8(10):e77034. PMID: 24204728.

Feher A, Cassuto J, Szabo A, et al. Increased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesity. Circ J. 2013;77(7):1867-76. PMID: 23603844.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • O6953

    Ornidazole

    5-Nitroimidazole derivative; genotoxic.
    ≥98%
  • N1983

    Neuropeptide Y (3-36), human

    Endogenous peptide neurotransmitter, involved in f...
    ≥95%
  • F4580

    FluM1 A2 Peptide (58-66)

    Peptide, influenza matrix protein M1 epitope.
    ≥95%
  • P3269

    Piroxicam

    NSAID; COX-1/2 inhibitor.
    ≥98%
  • A4852

    β-Amyloid Peptide (1-40)

    Endogenous APP peptide cleavage product, primary c...
    ≥95%
  • N6076

    N(p-Tosyl)-GPR-pNA

    Thrombin substrate used to measure thrombin activi...
    ≥95%
  • G5320

    GNF-2

    Abl inhibitor.
    ≥98%
  • S0269

    SAR245409

    Pyridopyrimidinone; PI3K and mTOR inhibitor.
    ≥96%
  • D5898

    Doxycycline Monohydrate

    Tetracycline; protein translation inhibitor, MMP i...
    ≥97%
  • A0249

    BAM-22P

    Peptide, cleavage product of proenkephalin; κOR a...
    ≥95%
  • C6018

    C-Peptide, dog

    Endogenous peptide, connects A and B chains of ins...
    ≥95%
  • R6871

    RR-SRC

    Src-derived tyrosine kinase substrate.
    ≥95%
  • A9714

    AZD-1152-HQPA

    AurKA/B inhibitor.
    ≥98%
  • N0075

    Natamycin

    Polyene macrolide; ergosterol inhibitor.
    ≥98%
  • F4680

    Flutamide

    Non-steroid; AR antagonist.
    ≥98%
  • T2835

    6-Thioguanine

    Nucleotide (guanine) analog, prevents guanine synt...
    ≥90%
  • P6854

    Progesterone

    Endogenous steroid hormone involved in reproductio...
    ≥98%
  • B3209

    Bicalutamide

    AR antagonist.
    ≥98%
  • F4856

    Fmoc-Lys(Boc)-Leu-Lys(Boc)

    Tripeptide used for glycation.
    ≥98%
  • S6130

    Sphingosine-1-Phosphate

    Endogenous sphingolipid involved in cell signaling...
    ≥98%